DCDaniele Canale

Daniele Canale

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniele Canale has a total of 81 co-authors. Here are the top co-authors by number of shared publications:

  • Rildo Aparecido Volpini

    Laboratorio de Investigacao Medica 12 (LIM12), Faculdade de Medicina, Hospital das Clinicas HCFMUSP Universidade de São Paulo São Paulo Brazil

    12 shared publications
  • Maria Heloisa Massola Shimizu

    Laboratorio de Investigacao Medica 12 (LIM12), Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil

    9 shared publications
  • Pedro Henrique França Gois

    Faculty of Health, Medicine and Behavioural Sciences, University of Queensland

    9 shared publications
  • Ana Carolina de Bragança

    Laboratorio de Investigacao Medica 12 (LIM12), Faculdade de Medicina, Hospital das Clinicas HCFMUSP, Universidade de São Paulo, São Paulo, Brazil

    8 shared publications
  • Antonio Carlos Seguro

    Laboratorio de Investigacao Medica 12 (LIM12), Faculdade de Medicina, Hospital das Clinicas HCFMUSP, Universidade de São Paulo, São Paulo, Brazil

    8 shared publications
  • Antonio C. Seguro

    5 shared publications

Latest Publications

  • Open Access

    Dapagliflozin treatment ameliorates oxidative stress, apoptosis and inflammation in tenofovir-induced nephrotoxicity in rats

    by Vitor Antonio dos Santos, Ana Carolina Rocha Viotto, Mariana Moura Nascimento, Desiree Rita Denelle Bernardo, Maria Heloisa Massola Shimizu, Claudia Ramos de Sena, Antonio Carlos Seguro, Rildo Aparecido Volpini, Ana Carolina de Bragança, Daniele Canale

    Tenofovir disoproxil fumarate is a widely prescribed component in antiretroviral therapy regimes frequently associated with nephrotoxicity. Dapagliflozin, an SGLT2 inhibitor, is primarily used as a hypoglycemic agent but is increasingly recognized for its pleiotropic protective effects. To investigate whether dapagliflozin could mitigate tenofovir-induced nephrotoxicity, Wistar rats were randomly assigned to four groups: Control- received a standard diet for 45 days, TDF- received a standard diet added with tenofovir (300 mg/kg food) for 45 days, DAPA- received a standard diet for 45 days added with dapagliflozin (20 mg/kg food) in the last 15 days, and TDF + DAPA- received a standard diet added with tenofovir for 45 days and dapagliflozin in the last 15 days. Dapagliflozin administration restored glomerular filtration rate, improved renal hemodynamic parameters and maintained the adequate balance of TBARS/GSH levels through the modulation of SIRT1/Nrf2/HO-1 signaling pathway and mitochondrial enzymatic antioxidant system-related markers. Furthermore, dapagliflozin treatment reduced inflammatory response and apoptotic cell death, marked by increased Bcl-2 expression and decreased levels of TLR4, NF-κB, pro-inflammatory cytokines, Bax, cytochrome c, and caspase-3. Dapagliflozin holds multifaceted renoprotective effects potentially offering a therapeutic strategy to slow the progression of kidney injury in tenofovir-induced nephrotoxicity.


  • Open Access

    Administration of a single dose of lithium ameliorates rhabdomyolysis-associated acute kidney injury in rats

    by Maria Heloisa Massola Shimizu, Rildo Aparecido Volpini, Ana Carolina de Bragança, Mariana Moura Nascimento, Desiree Rita Denelle Bernardo, Antonio Carlos Seguro, Daniele Canale

    Rhabdomyolysis is characterized by muscle damage and leads to acute kidney injury (AKI). Clinical and experimental studies suggest that glycogen synthase kinase 3β (GSK3β) inhibition protects against AKI basically through its critical role in tubular epithelial cell apoptosis, inflammation and fibrosis. Treatment with a single dose of lithium, an inhibitor of GSK3β, accelerated recovery of renal function in cisplatin and ischemic/reperfusion-induced AKI models. We aimed to evaluate the efficacy of a single dose of lithium in the treatment of rhabdomyolysis-induced AKI. Male Wistar rats were allocated to four groups: Sham, received saline 0.9% intraperitoneally (IP); lithium (Li), received a single IP injection of lithium chloride (LiCl) 80 mg/kg body weight (BW); glycerol (Gly), received a single dose of glycerol 50% 5 mL/kg BW intramuscular (IM); glycerol plus lithium (Gly+Li), received a single dose of glycerol 50% IM plus LiCl IP injected 2 hours after glycerol administration. After 24 hours, we performed inulin clearance experiments and collected blood / kidney / muscle samples. Gly rats exhibited renal function impairment accompanied by kidney injury, inflammation and alterations in signaling pathways for apoptosis and redox state balance. Gly+Li rats showed a remarkable improvement in renal function as well as kidney injury score, diminished CPK levels and an overstated decrease of renal and muscle GSK3β protein expression. Furthermore, administration of lithium lowered the amount of macrophage infiltrate, reduced NFκB and caspase renal protein expression and increased the antioxidant component MnSOD. Lithium treatment attenuated renal dysfunction in rhabdomyolysis-associated AKI by improving inulin clearance and reducing CPK levels, inflammation, apoptosis and oxidative stress. These therapeutic effects were due to the inhibition of GSK3β and possibly associated with a decrease in muscle injury.


  • Open Access

    Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats

    by Mariana Moura Nascimento, Desiree Rita Denelle Bernardo, Ana Carolina de Bragança, Maria Heloisa Massola Shimizu, Antonio Carlos Seguro, Rildo Aparecido Volpini, Daniele Canale

    Background: Tenofovir disoproxil fumarate (TDF), a widely prescribed component in antiretroviral regimens, has been associated with nephrotoxicity. Nebivolol is a third generation selective β-1 adrenergic receptor blocker and may protect renal structure and function through the suppression of oxidative stress and enhancement of nitric oxide (NO) synthesis. We aimed to investigate whether nebivolol could be an effective therapeutic strategy to mitigate tenofovir-induced nephrotoxicity.Methods: We allocated Wistar rats to four groups: control (C), received a standard diet for 30 days; NBV, received a standard diet for 30 days added with nebivolol (100 mg/kg food) in the last 15 days; TDF, received a standard diet added with tenofovir (300 mg/kg food) for 30 days; and TDF+NBV, received a standard diet added with tenofovir for 30 days and nebivolol in the last 15 days.Results: Long-term exposure to tenofovir led to impaired renal function, induced hypertension, endothelial dysfunction and oxidative stress. Nebivolol treatment partially recovered glomerular filtration rate, improved renal injury, normalized blood pressure and attenuated renal vasoconstriction. Administration of nebivolol contributed to reductions in asymmetric dimethylarginine (ADMA) levels as well as increases in endothelial nitric oxide sintase (eNOS) accompanied by renin-angiotensin-aldosterone system downregulation and decreases in macrophage and T-cells infiltrate. Furthermore, nebivolol was responsible for the maintenance of the adequate balance of thiobarbituric acid reactive substances (TBARS) and glutathione (GSH) levels and it was associated with reductions in NADPH oxidase (NOX) subunits.Conclusion: Nebivolol holds multifaceted actions that promote an advantageous option to slow the progression of kidney injury in tenofovir-induced nephrotoxicity.


  • Open Access

    Vitamin D deficiency is a potential risk factor for lipid Amphotericin B nephrotoxicity

    by Daniela Ferreira, Ana Carolina de Bragança, Rildo Aparecido Volpini, Maria Heloisa Massola Shimizu, Pedro Henrique França Gois, Adriana Castello Costa Girardi, Antonio Carlos Seguro, Daniele Canale

    Invasive fungal infections (IFI) is a worldwide serious health problem and Amphotericin B (AmB) has been considered the drug of choice for IFI treatment. Despite its efficacy, clinical use of AmB has been associated with renal toxicity. Some lines of evidence have shown that an extemporaneous lipid emulsion preparation of AmB (AmB/LE) was able to attenuate nephrotoxicity, presenting similar benefits at a lower cost. Studies have been demonstrating that hypovitaminosis D may hasten the progression of kidney disease and reflect on a worse prognosis in cases of drug-induced nephrotoxicity. In view of the high worldwide incidence of hypovitaminosis D, the aim of this study was to investigate whether vitamin D deficiency may induce AmB/LE-related nephrotoxicity. Wistar rats were divided into four groups: control, received a standard diet for 34 days; AmB/LE, received a standard diet for 34 days and AmB/LE (5 mg/kg/day) intraperitoneally in the last 4 days; VDD, received a vitamin D-free diet for 34 days; and VDD+AmB/LE, received a vitamin D-free diet for 34 days and AmB/LE as described. At the end of the protocol, animals were euthanized and blood, urine and renal tissue samples were collected in order to evaluate AmB/LE effects on renal function and morphology. Association of AmB/LE and vitamin D deficiency led to diminished glomerular filtration rate and increased tubular injury, evidenced by reduced renal protein expression of NaPi-IIa and TRPM6 leading to hyperphosphaturia / hypermagnesuria. VDD+AmB/LE rats also presented alterations in the PTH-Klotho-FGF-23 signaling axis, urinary concentrating defect and hypertension, probably due to an inappropriate activation of the renin-angiotensin-aldosterone system. Hence, it is important to monitor vitamin D levels in AmB/LE treated patients, since vitamin D deficiency induces AmB/LE nephrotoxicity. Amphotericin B (AmB) is the treatment of choice for systemic fungal infections. Despite its efficacy, clinical use of AmB has been associated with renal toxicity. In an attempt to improve the therapeutic effect and to reduce adverse reactions, lipid formulations of AmB were developed. Among these formulations, an in-house lipid emulsion preparation of AmB (AmB/LE) is a lower cost alternative with similar benefits. Furthermore, vitamin D is an essential nutrient for the regulation of several physiological activities. Hence, vitamin D deficiency or insufficiency can contribute to the progression of diseases and increase the risk of chronic illnesses as well. Nowadays, VDD is a health problem worldwide and its prevalence in general population is high, including the sunny and industrialized countries, where vitamin D supplementation has been successfully implemented. Thus, it is essential to monitor vitamin D levels in both patients treated with conventional or lipid formulations of AmB in order to ensure a better prognosis in the development of renal diseases.


  • Open Access

    Correction: Ecstasy induces reactive oxygen species, kidney water absorption and rhabdomyolysis in normal rats. Effect of N-acetylcysteine and Allopurinol in oxidative stress and muscle fiber damage

    by Ana C. de Bragança, Regina L. M. Moreau, Thales de Brito, Maria H. M. Shimizu, Daniele Canale, Denise A. de Jesus, Ana M. G. Silva, Pedro H. Gois, Antonio C. Seguro, Antonio J. Magaldi

    [This corrects the article DOI: 10.1371/journal.pone.0179199.].


  • Vitamin D, Oxidative Stress, and the Antiretroviral Tenofovir

    by Antonio C. Seguro, Pedro H. França Gois, Daniele Canale


  • Open Access

    Allopurinol attenuates acute kidney injury following Bothrops jararaca envenomation

    by Pedro Henrique França Gois, Monique Silva Martines, Daniela Ferreira, Rildo Volpini, Daniele Canale, Ceila Malaque, Renato Crajoinas, Adriana Castello Costa Girardi, Maria Heloisa Massola Shimizu, Antonio Carlos Seguro

    Snakebites have been recognized as a neglected public health problem in several tropical and subtropical countries. Bothrops snakebites frequently complicate with acute kidney injury (AKI) with relevant morbidity and mortality. To date, the only treatment available for Bothrops envenomation is the intravenous administration of antivenom despite its several limitations. Therefore, the study of novel therapies in Bothrops envenomation is compelling. The aim of this study was to evaluate the protective effect of Allopurinol (Allo) in an experimental model of Bothrops jararaca venom (BJ)-associated AKI. Five groups of Wistar rats were studied: Sham, Allo, BJ, BJ+Allo, BJ+ipAllo. BJ (0.25 mg/kg) was intravenously injected during 40’. Saline at same dose and infusion rate was administered to Sham and Allo groups. Allo and BJ+Allo groups received Allo (300 mg/L) in the drinking water 7 days prior to Saline or BJ infusion respectively. BJ+ipAllo rats received intraperitoneal Allo (25 mg/Kg) 40’ after BJ infusion. BJ rats showed markedly reduced glomerular filtration rate (GFR, inulin clearance) associated with intense renal vasoconstriction, hemolysis, hemoglobinuria, reduced glutathione and increased systemic and renal markers of nitro-oxidative stress (Nitrotyrosine). Allo ameliorated GFR, renal blood flow (RBF), renal vascular resistance and arterial lactate levels. In addition, Allo was associated with increased serum glutathione as well as reduced levels of plasma and renal Nitrotyrosine. Our data show that Allo attenuated BJ-associated AKI, reduced oxidative stress, improved renal hemodynamics and organ perfusion. It might represent a novel adjuvant approach for Bothrops envenomation, a new use for an old and widely available drug. Snakebites have been recognized as a neglected public health problem in several tropical and subtropical countries. Snakes from the genus Bothrops are the most common snakes found in Latin America. Bothrops snakebites frequently complicate with kidney impairment with increased risk of death. The only treatment currently available for Bothrops envenomation is the infusion of antivenom. Therefore, the study of novel therapies to prevent kidney failure caused by snakebites is compelling. Allopurinol is a drug commonly used to treat gout which also presents beneficial antioxidant properties. The aim of this study was to evaluate the protective effect of Allopurinol in a rat experimental model of Bothrops envenomation. In our study, rats that received the infusion of the snake venom presented with reduced kidney function which was improved by Allopurinol. Overall, Allopurinol might represent a novel approach to prevent kidney failure in victims of Bothrops snakebites. This could be a new use for an old and widely available drug.


  • Open Access

    Ecstasy induces reactive oxygen species, kidney water absorption and rhabdomyolysis in normal rats. Effect of N-acetylcysteine and Allopurinol in oxidative stress and muscle fiber damage

    by Ana C De Bragança, Regina L M Moreau, Thales De Brito, Maria H M Shimizu, Daniele Canale, Denise A De Jesus, Ana M G Silva, Pedro H Gois, Antonio C Seguro, Antonio J Magaldi

    Ecstasy (Ec) use produces hyperthermia, excessive sweating, intense thirst, an inappropriate antidiuretic hormone secretion (SIADH) and a multisystemic toxicity due to oxidative stress (OS). Intense thirst induces high intake of pure water, which associated with SIADH, usually develops into acute hyponatremia (Hn). As Hn is induced rapidly, experiments to check if Ec acted directly on the Inner Medullary Collecting Ducts (IMCD) of rats were conducted. Rhabdomyolysis and OS were also studied because Ec is known to induce Reactive Oxygen Species (ROS) and tissue damage. To decrease OS, the antioxidant inhibitors N-acetylcysteine (NAC) and Allopurinol (Allo) were used. Rats were maintained on a lithium (Li) diet to block the Vasopressin action before Ec innoculation. AQP2 (Aquaporin 2), ENaC (Epitheliun Sodium Channel) and NKCC2 (Sodium, Potassium, 2 Chloride) expression were determined by Western Blot in isolated IMCDs. The TBARS (thiobarbituric acid reactive substances) and GSH (reduced form of Glutathione) were determined in the Ec group (6 rats injected with Ec-10mg/kg), in Ec+NAC groups (NAC 100mg/Kg/bw i.p.) and in Allo+Ec groups (Allo 50mg/Kg/i.p.). Enhanced AQP2 expression revealed that Ec increased water transporter expression, decreased by Li diet, but the expression of the tubular transporters did not change. The Ec, Ec+NAC and Allo+Ec results showed that Ec increased TBARS and decreased GSH, showing evidence of ROS occurrence, which was protected by NAC and Allo. Rhabdomyolysis was only protected by Allo. Results showed that Ec induced an increase in AQP2 expression, evidencing another mechanism that might contribute to cause rapid hyponatremia. In addition, they showed that NAC and Allo protected against OS, but only Allo decreased rhabdomyolysis and hyperthermia.


  • Open Access

    Lp25 membrane protein from pathogenic Leptospira spp. is associated with rhabdomyolysis and oliguric acute kidney injury in a guinea pig model of leptospirosis

    by Patrícia A E Abreu, Antonio C Seguro, Daniele Canale, Ana Maria G Da Silva, Larissa Do R B Matos, Tatiane B Gotti, Denize Monaris, Denise A De Jesus, Sílvio A Vasconcellos, Thales De Brito, et al.

    Acute kidney injury (AKI) from leptospirosis is frequently nonoliguric with hypo- or normokalemia. Higher serum potassium levels are observed in non-survivor patients and may have been caused by more severe AKI, metabolic disarrangement, or rhabdomyolysis. An association between the creatine phosphokinase (CPK) level and maximum serum creatinine level has been observed in these patients, which suggests that rhabdomyolysis contributes to severe AKI and hyperkalemia. LipL32 and Lp25 are conserved proteins in pathogenic strains of Leptospira spp., but these proteins have no known function. This study evaluated the effect of these proteins on renal function in guinea pigs. Lp25 is an outer membrane protein that appears responsible for the development of oliguric AKI associated with hyperkalemia induced by rhabdomyolysis (e.g., elevated CPK, uric acid and serum phosphate). This study is the first characterization of a leptospiral outer membrane protein that is associated with severe manifestations of leptospirosis. Therapeutic methods to attenuate this protein and inhibit rhabdomyolysis-induced AKI could protect animals and patients from severe forms of this disease and decrease mortality. Rhabdomyolysis is a syndrome that results from the disruption of skeletal muscle integrity, leading to a massive release of the intracellular contents into the blood stream, including myoglobin, creatine phosphokinase, aspartate transaminase, lactate dehydrogenase, aldolase, and electrolytes. Complications of rhabdomyolysis include acute kidney injury (AKI), hyperkalemia, hyperphosphatemia, and hypovolemia, which may result in death without early treatment. The most frequent causes of this syndrome are trauma, excessive muscle activity, drugs, toxins, electrolyte imbalance, muscle ischemia, metabolic disorders, and infectious diseases. Among leptospirosis cases, the AKI induced by rhabdomyolysis has been described almost exclusively in patients with severe form of leptospirosis. However, the role of rhabdomyolysis in the pathogenesis of AKI due to leptospiral infection is not understood.


  • Allopurinol attenuates rhabdomyolysis-associated acute kidney injury: Renal and muscular protection

    by Pedro H.F. Gois, Daniele Canale, Rildo A. Volpini, Daniela Ferreira, Mariana M. Veras, Vinicius Andrade-Oliveira, Niels O.S. Câmara, Maria H.M. Shimizu, Antonio C. Seguro